H.C. Wainwright Reiterates Buy Rating on Immunic Inc. (IMUX)

May 14, 2026 6:50 AM

H.C. Wainwright analyst Andrew Fein reiterated a Buy rating and $22.00 price target on Immunic Inc. (NASDAQ: IMUX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found